ARMISTICE CAPITAL LLC 13D and 13G filings for Checkpoint Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:38 pm Purchase | 2024-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 5,216,445 9.990% | 642,699 (+14.05%) | Filing |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 4,573,746 9.990% | 1,858,111 (+68.42%) | Filing |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 2,715,635 9.990% | 1,728,424 (+175.08%) | Filing |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 987,211 9.990% | 987,211 (New Position) | Filing |